Story not found
← Return to briefingA pancreatic cancer patient, Ben Sasse, has experienced a significant reduction in tumor size. This development is attributed to an experimental new drug. The reduction in tumor size is described as massive.
Further information about this case can be found through Fox 26 Houston. Details about the experimental drug and Ben Sasse's treatment are available from the source, Fox 26 Houston, based in The Woodlands, TX.
This preview is provided by The Woodlands News. Full article available at .
Recent coverage curated from local and regional sources.
A person was killed and another was injured in a shooting in northeast Houston on Friday afternoon, authorities said.
Due to his previous employment at The Galloway School, police believe the suspect may have assaulted other children.
Scattered thundershowers will again pop up on Sunday afternoon, and those rain chances will climb even more Monday as tropical air visits Ho…
One person was pronounced deceased at the scene on Mesa Drive.
The suspect is reported to have told investigators that he would harm the family's kittens in front of his daughter as punishment.
The suspect's father called 911 reporting that he and wife had been stabbed Friday night.
Friendswood PD is asking parents who believe their children may have had contact with Lewis Stott, a former teacher at The Galloway School, …
U.S. Immigration and Customs Enforcement said it expects every officer and agent in the field to be equipped with a body camera by the end o…
The NHC is monitoring a tropical wave in the eastern Atlantic with a 20% chance of development.
Juan Jose Uribe Pelaez, 32, is being held on a $500,000 bond after he allegedly stabbed both of his parents, killing his mother and injuring…
Former U.S. President Joe Biden's prostate cancer has spread to other parts of his body and is causing him pain, his son Hunter said in an i…
Officers said the driver, who was in a small white sedan, took off without helping.
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.